CAH, Cardinal Health

Cardinal Health (NYSE:CAH) Beats Q4 Sales Targets
Healthcare distributor and services company Cardinal Health (NYSE:CAH) beat Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 3.8% year on year to $55.26 billion. Its non-GAAP profit of $1.
CAH Q2 Earnings and Sales Beat Estimates, 2025 EPS View Raised
Cardinal Health, Inc. CAH reported second-quarter fiscal 2025 adjusted earnings per share (EPS) of $1.93, which beat the Zacks Consensus Estimate of $1.75 by 10.3%. The bottom line also improved 2.1% year over year.
Bank of America Securities Reaffirms Their Buy Rating on Cardinal Health (CAH)
Bank of America Securities analyst Allen Lutz maintained a Buy rating on Cardinal Health (CAH – Research Report) today. The company’s shares
Cardinal Health Inc (CAH) Q2 2025 Earnings Call Highlights: Strong Pharma Growth Amid Revenue ...
Cardinal Health Inc (CAH) raises EPS guidance despite a 4% revenue decline, driven by robust pharmaceutical segment performance and strategic acquisitions.
Cardinal Health, Inc. (NYSE:CAH) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript January 30, 2025 Cardinal Health, Inc. beats earnings expectations. Reported EPS is $1.93, expectations were $1.74. Operator: Hello, and welcome to the Second Quarter Fiscal Year 2025 Cardinal Health Inc.
Cardinal Health, Inc. (CAH) Q2 2025 Earnings Call Transcript
Hello, and welcome to the Second Quarter Fiscal Year 2025 Cardinal Health Inc. Earnings Conference Call. My name is George, and I'll be coordinator for today's event. Please note, this conference is being recorded.
Earnings call transcript: Cardinal Health Q2 2024 beats forecasts, stock dips
Cardinal Health (NYSE:CAH) reported its second-quarter earnings for fiscal year 2024, surpassing analyst expectations with an earnings per share (EPS) of $1.93 compared to the forecasted $1.77. Revenue also exceeded projections,
Cardinal Health (NYSE:CAH) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
Cardinal Health (NYSE:CAH – Get Free Report) had its target price hoisted by equities researchers at Wells Fargo & Company from $127.00 to $135.00 in a research note issued on Wednesday,Benzinga ...
Cardinal Health’s Strong Performance and Strategic Acquisitions Justify Buy Rating
Mizuho Securities analyst Steven Valiquette has reiterated their bullish stance on CAH stock, giving a Buy rating yesterday.Invest with ...
Seeking Alpha1d
CAH Cardinal Health, Inc.
**NM signifies a non meaningful value. A dash signifies the data is not available.
Morningstar2d
Cardinal Health Inc CAH
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...